NET patient videos

The neuroendocrine tumour (NET) team at the Royal Free Hospital have produced a number of videos to help you find out more about NET. You can watch all the videos on our YouTube channel.

 

NET patient CarmenPatient experience talk and PRRT updates - Mark Zwanziger

Patient experience talk and PRRT updates, at the neuroendocrine tumour support group 21 August 2018.

 

NET patient CarmenWelfare advice talk at NET patient day August 2018 - Lucis Crème

Introduction to welfare advice and support at the neuroendocrine tumour support group 21st August 2018 by Lucis Crème, Macmillan Welfare Benefits Adviser.

 

NET patient CarmenPatients celebrate 20 years of care for treatment of ‘quiet cancer’ - Carmen.

Patients and staff are celebrating the 20th anniversary of the neuroendocrine tumour (NET) unit at the Royal Free Hospital, which is helping tackle a rare condition known as neuroendocrine (carcinoid) tumour, sometimes referred to as the ‘quiet cancer’.

 

NET patient RosePatients celebrate 20 years of care for treatment of ‘quiet cancer’ - Rose.

Patients and staff are celebrating the 20th anniversary of the neuroendocrine tumour (NET) unit at the Royal Free Hospital, which is helping tackle a rare condition known as neuroendocrine (carcinoid) tumour, sometimes referred to as the ‘quiet cancer’.

 

NET patient JohnPatients celebrate 20 years of care for treatment of ‘quiet cancer’ - John.

Patients and staff are celebrating the 20th anniversary of the neuroendocrine tumour (NET) unit at the Royal Free Hospital, which is helping tackle a rare condition known as neuroendocrine (carcinoid) tumour, sometimes referred to as the ‘quiet cancer’.

 

Professor Martyn CaplinProfessor Martyn Caplin and Consultant and Radiologist Dr Dominic Yu at 9th NET patient support group.

Introduction and  Interventional radiology procedures neuroendocrine tumour patients undergo.

 

Kym WintersPsychotherapist and counsellor Kym Winters at 9th NET patient support group.

Living with uncertainty: managing the emotional impact of a chronic condition.

 

Diagnosed NET patientDiagnosed NET patient Peter. M at 9th NET patient support group meeting.

Peter. M - a NET diagnosed patient who talks bravely about living with a Neuroendocrine Tumour.

 

Aisling McSweeneyClinical Nurse Specialist Aisling McSweeney at 9th NET patient support group meeting.

Chair of the Meeting (Q&A’s).

 

Jorge Garcia-HernandezJorge Garcia-Hernandez introduces the 8th NET patient support group meeting

Jorge Garcia-Hernandez introduces the speakers at the 8th NET Patient support meeting.

 

Kito FusaiMr Kito Fusai at the 8th NET patient support group

At the 8th neuroendocrine tumour team (NET) at the Royal Free Hospital, Mr Kito Fusai gives a talk on Pancreatic surgery.

 

Yasmin ChotaiYasmin Chotai at the 8th NET patient support group

At the 8th neuroendocrine tumour team (NET) at the Royal Free Hospital, Yasmin Chotai gives a talk on diet and nutrition.

NET patient JaneNET patient story: diagnosis to treatment

Jane, a NET patient, was recently diagnosed. Here she shares her story from diagnosis to recent treatment in an informal interview.

 

Jorge Garcia-HernandezNET: clinical studies

Jorge Garcia-Hernandez, medical statistician, gives a talk on the up and running studies held at the neuroendocrine unit at the Royal Free Hospital.

 

Dr ToumpanakisNET treatment and management: an update

Dr Toumpanakis provides an update on the treatment and management of neuroendocrine tumours.

 

Charles SucklingPatient and partner experience of NET

Charles Suckling, a NET patient, shares with us his story from diagnosis to present day, including the perspective of his partner.

 

Dr Dalvinder MandairAdvances in NET research: present and future

Dr Dalvinder Mandair gives a technical talk on advances in neuroendocrine tumours: present and future.

 

Mike WrightNET fundraising: upcoming events

Mike Wright and Jorge Garci-Hernandez, NET patient coordinators, provide an update on all upcoming fundraising events at the Royal Free London.

 

Lucy PowerNET fundraising: Royal Free Charity

Lucy Power, database administrator at the Royal Free Charity, gives us an update on the charity's work at the Royal Free Hospital.

 

Philippa DaviesNET symptom management

Philippa Davies, lead nurse for neuroendocrine tumours at the Royal Free Hospital, provides an excellent and detailed overview of symptom management.

 

Jorge Garcia-HernandezComplementary therapy do's and don'ts

Jorge Garcia-Hernandez, NET patient coordinator and medical statistician, presents the do's and don'ts of complementary therapies.

 

Mike WrightNET fundraising scheme

Mike Wright, NET patient co-ordinator, discusses the NET fundraising scheme and organises the first NET park run. Please join us on 5 December 2015.

 

Keith Hunt MBEA treat on top of the treatment

Keith Hunt MBE, complementary therapies co-ordinator, talks about how gentle massage can help with the stress of daily life.

Pancreatic NET patientPatient story: diagnosis to present day

A pancreatic NET patient tell us her journey from diagnoses to present day.

Radiotargetted therapy patientPatient story: radiotargetted therapy

A patient tell us her remarkable story after receiving radiotargetted therapy under Prof Caplin's care.

 

Meet Professor Martyn Caplin

Professor Martyn Caplin is the lead clinician at the neuroendocrine unit at the Royal Free London and the Chair of the European Neuroendocrine Tumour Society. Prof Caplin welcomed the first NET patient support group in July 2014 with an a overview of neuroendocrine tumours.

 

Meet Flora, a clinical nurse specialist

Flora Dangwa, experienced clinical nurse specialist, tell us her experience in running different support groups.

 

Meet Jorge, a senior research nurse

Jorge Garcia-Hernandez, former senior research nurse, talks about the different trials run at the NET unit and how patients can influence research.

Meet Maia, from the NET patient foundation

Maia Simmons from the NET patient foundation explains the role of the foundation and the different NET Natter supports groups across the country.

 

Patient story: travel insurance

A NET patient relates his experience of travel insurance issues in NETs and gives advice to those who have a NET and wish to travel.

 

Open discussion on travel insurance

Jorge Garcia-Hernandez, NET patient coordinator and senior research nurse, pulls together the comments, experiences and findings regarding travel insurance for patients with cancer, particularly neuroendocrine tumours.

 

Meet Dr Toumpanakis, consultant in gastroenterology and NET

Dr Christos Toumpanakis, consultant in gastroenterology and neuroendocrine tumours, provides a passionate overview of the role in clinical trials at improving patient care.  In particular, Dr Toumpanakis tell us the paradox of patients presenting with similar diagnosis but having different outcomes.

 

Neuroendocrine tumours: the quiet cancer

Dr Christos Toumpanakis (MD PhD), consultant in gastroenterology and neuroendocrine tumours at the Royal Free London, and Jorge Garcia-Hernandez, senior research nurse at the Royal Free London, present 'Neuroendocrine tumours: the quiet cancer', at a Royal Free London Medicine for members event.

Diet and nutrition for patients with NET

Tara Whyand, specialist NET dietician, gives hints and tips on diet and nutrition for patients with NET and debunks some of the common myths regarding healthy eating for people with cancer.

 

Q&A with Tara, specialist NET dietitian

Tara Whyand, specialist NET dietitian, answers questions on diet and nutrition.

 

Molecular agents from a patient perspective

Liz Quaglia, clinical nurse specialist in NETs, provides a comprehensive evaluation of the molecular agents, sunitinib and everolimus, from a patient perspective.

 

NET research: genetic advances

Dr Chrissie Thirlwell provides an overview on the advances of NET research from the genetic perspective. Focusing on advances, caveats and the future.

 

NET discussion with Dr Navalkissoor

Dr Navalkissoor, nuclear medicine consultant, comprehensively explains the advances in NET treatment with radiotargeted therapy (PRRT). Particular attention is given to the molecule 177-Lutetium.

NET Q&A with Dr Navalkissoor

Dr Navalkissoor, nuclear medicine consultant, answers questions on the advances in NET treatment.

 

Meet Diane, fundraising manager

Diane Ryan, fundraising manager at the Royal Free Charity speaks about the role of the charity in supporting the NET unit and the patient support group.

 

 

PRRT and NICE  appraisal update - download presentation here.